Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Bliv vs Corsica Health

Bliv
Graded #164

Higher grade

vs+1.2999999999999972
Corsica Health
Graded #193

Lower grade

The verdict

Bliv takes it — 67.6/100 to 66.3/100, but only just.

Bliv grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth provider focused on personalized GLP-1 weight loss programs. Corsica Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBliv +28
76
48
Dose & formulationCorsica Health +13
64
77
Clinical oversightCorsica Health +5
82
87
Labs & monitoringCorsica Health +1
53
54
FulfillmentCorsica Health +10
65
75
Contract termsCorsica Health +10
45
55
Bliv · left barCorsica Health · right bar

The numbers

MetricBlivCorsica Health
WeighScore67.6/10066.3/100
GradeCC
Scorecard rank#164#193
Semaglutide$58/mo (starting dose, compounded)$249/mo (compounded)
Tirzepatide$99/mo (starting dose, compounded)$349/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Bliv

Graded #164 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
Corsica Health

Graded #193 · C

Strengths

  • Public pricing shown for both compounded and brand-name options — a real transparency advantage
  • $1,499/mo brand-name Wegovy/Ozempic/Mounjaro is below typical retail cash-pay
  • LegitScript Certified
  • Clear 3-step intake: Assessment, Provider Review, Receive Medication
  • $199/mo compounded semaglutide and $249/mo compounded tirzepatide (3-month plans) are competitively priced

Where it loses points

  • Legal entity name and state of incorporation not disclosed on the site
  • Pharmacy partner described only as a 'licensed compounding pharmacy,' not named
  • Per-state availability not listed publicly
  • First-month promotional pricing not disclosed
  • Lab-work inclusion not clearly disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard